• Oxaliplatin: Mechanisms and Innovations in Platinum-Based...

  2025-09-28

  Explore the advanced mechanisms of Oxaliplatin, a platinum-based chemotherapeutic agent, and its pioneering role in metastatic colorectal cancer therapy. Discover how emerging assembloid models are transforming preclinical drug testing and personalizing treatment strategies.

• SCH772984 HCl: Advanced ERK1/2 Inhibition Strategies in C...

  2025-09-27

  Explore the multifaceted role of SCH772984 HCl, a selective ERK1/2 inhibitor, in targeting MAPK pathway dysregulation in cancer and stem cells. This article offers an in-depth, mechanistic analysis and highlights new research intersections beyond standard oncology applications.

• L1023 Anti-Cancer Compound Library: Accelerating Function...

  2025-09-26

  Explore how the L1023 Anti-Cancer Compound Library enables functional target validation and novel pathway discovery in cancer research. This in-depth article reveals distinct strategies for leveraging this anti-cancer compound library for drug discovery and translational breakthroughs.

• 5-Ethynyl-2'-deoxyuridine (5-EdU) for Quantitative S Phas...

  2025-09-25

  Explore how 5-Ethynyl-2'-deoxyuridine (5-EdU) revolutionizes click chemistry cell proliferation detection and enables precise S phase DNA synthesis labeling for advanced studies in tissue regeneration, tumor growth, and cell cycle analysis. This article uniquely bridges molecular mechanisms with translational applications, offering insights distinct from existing guides.

• Protease Inhibitor Cocktail EDTA-Free (100X): Enabling Pr...

  2025-09-24

  Discover how the Protease Inhibitor Cocktail EDTA-Free (100X in DMSO) revolutionizes protein extraction and complex purification by ensuring robust protease activity inhibition without compromising phosphorylation analysis. This article explores advanced mechanistic insights and strategic applications beyond standard protocols.

• HyperScribe™ T7 High Yield RNA Synthesis Kit for Post-Tra...

  2025-09-23

  Explore the application of the HyperScribe™ T7 High Yield RNA Synthesis Kit in cutting-edge research on RNA modifications, including N4-acetylcytidine-mediated post-transcriptional regulation, with insights for RNA vaccine research, RNA interference, and epitranscriptomic investigations.

• IC values were obtained for an expanded version of

  2025-04-22

  

  IC50 values were obtained for an expanded version of the fragment library using the previously described mobility shift assay. Subsequently, Ki values were estimated from IC50 values to allow better comparison of the activity against targets which were measured at different substrate concentrations

• Because the V ATPase inhibitors that have

  2025-04-21

  

  Because the V-ATPase inhibitors that have been employed in these studies (including bafilomycin and concanamycin), are membrane permeant, they inhibit all the V-ATPases in the cell. This is important since it is possible that intracellular V-ATPases, in addition to those present at the plasma membra

• Loss of expression or functional activity of cell adhesion i

  2025-04-18

  

  Loss of expression or functional activity of cell adhesion is intricately related to advanced stages of tumour progression and invasiveness. Martin-Belmonte and Perez-Moreno recently mentioned that the deregulation of adhesion can alter tumourgenesis in the early stage. We have shown for the first t

• Cerebral ischemia occurs following the occlusion of a cerebr

  2025-04-16

  

  Cerebral ischemia occurs following the occlusion of a cerebral artery by a thrombus and causes cell swelling due to cytotoxic edema and BBB disruption with vasogenic edema (Loreto and Reggio, 2010, Nakaji et al., 2006, Shibata et al., 2004). Vasogenic edema is directly linked to alteration of the BB

• The presence of crown like structures

  2025-04-14

  

  The presence of crown-like structures and inflammatory factors in the breast of obese patients is associated with considerable changes in intracellular signaling and a profound cellular dysfunction. Secreted pro-inflammatory factors can directly promote breast carcinogenesis as they have been report

• In order to determine whether the

  2025-04-12

  

  In order to determine whether the faster Rh2-induced apoptosis is specific of cholesterol depletion, we determined the cytotoxic effect of Rh2 in Cell Counting Kit-8 (CCK-8) depleted or not in sphingomyelin, another abundant plasma membrane lipid exhibiting enrichment in lipid rafts. We showed that,

• EZ Cap™ Firefly Luciferase mRNA (5-moUTP) The mitochondrial

  2025-04-12

  

  The mitochondrial protein AIF was the first caspase-independent death effector. AIF can induce caspase-independent chromatin condensation and large-scale DNA fragmentation to approximately 50 KB. AIF that is released to cytoplasm can mediate apoptosis when special extracellular signals trigger the o

• HotStart™ 2X Green qPCR Master Mix The levels of Mcl and

  2025-04-11

  

  The levels of Mcl-1 and FLIP are homeostatically controlled by transcriptional and posttranslational processes. Accumulating evidence suggested that intracellular signaling molecules such as Akt are crucial to the transcription of Mcl-1 and FLIP [30], [31]. The constitutive activation of Akt is dete

• The finding of the apelin APJ axis represents an impressive

  2025-04-11

  

  The finding of the apelin/APJ axis represents an impressive event in cardiovascular studies. As a result of various experimental and clinical studies conducted in vivo and in vitro, it has been indicated that apelin/APJ is a crucial mediator of cardiovascular homeostasis, which takes part in the pat

16793 records 15/1120 page Previous Next First page 上5页 1112131415 下5页 Last page